Literature DB >> 16248787

Peptide nucleic acid conjugates: synthesis, properties and applications.

Zhanna V Zhilina1, Amy J Ziemba, Scot W Ebbinghaus.   

Abstract

Artificial control of gene expression has great potential in the treatment of many human diseases, and peptide nucleic acids (PNAs) offer several potential advantages for silencing gene expression in mammalian cells. The pseudopeptide backbone of the PNA makes it resistant to enzymatic degradation, and PNAs bind complementary DNA and RNA with high affinity and specificity. PNAs are potentially leading agents for antigene and antisense therapeutics, but the application of PNAs in the in vivo setting is hampered by their poor intracellular delivery. This problem has been addressed by PNA conjugation to lipophilic moieties, peptides, and cell-specific receptor ligands. The biological activity of PNAs can also benefit from conjugation to DNA interactive compounds like intercalators and alkylators. Here we review the most interesting literature concerning PNA conjugation with small molecules, emphasizing synthetic approaches, properties and applications of the PNA conjugates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16248787     DOI: 10.2174/156802605774370892

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  12 in total

1.  Dual peptide nucleic acid- and peptide-functionalized shell cross-linked nanoparticles designed to target mRNA toward the diagnosis and treatment of acute lung injury.

Authors:  Ritu Shrestha; Yuefei Shen; Kevin A Pollack; John-Stephen A Taylor; Karen L Wooley
Journal:  Bioconjug Chem       Date:  2012-02-28       Impact factor: 4.774

2.  Molecular dynamics study of small PNA molecules in lipid-water system.

Authors:  Pawel Weronski; Yi Jiang; Steen Rasmussen
Journal:  Biophys J       Date:  2007-02-16       Impact factor: 4.033

3.  Cationic shell-cross-linked knedel-like (cSCK) nanoparticles for highly efficient PNA delivery.

Authors:  Huafeng Fang; Ke Zhang; Gang Shen; Karen L Wooley; John-Stephen A Taylor
Journal:  Mol Pharm       Date:  2009 Mar-Apr       Impact factor: 4.939

4.  Phospholipid conjugate for intracellular delivery of peptide nucleic acids.

Authors:  Gang Shen; Huafeng Fang; Yinyin Song; Agata A Bielska; Zhenghui Wang; John-Stephen A Taylor
Journal:  Bioconjug Chem       Date:  2009-09       Impact factor: 4.774

5.  Inhibition of HIV Replication by Cyclic and Hairpin PNAs Targeting the HIV-1 TAR RNA Loop.

Authors:  Gregory Upert; Audrey Di Giorgio; Alok Upadhyay; Dinesh Manvar; Nootan Pandey; Virendra N Pandey; Nadia Patino
Journal:  J Nucleic Acids       Date:  2012-09-17

Review 6.  MicroRNAs in brain metastases: potential role as diagnostics and therapeutics.

Authors:  Samer Alsidawi; Ehsan Malek; James J Driscoll
Journal:  Int J Mol Sci       Date:  2014-06-11       Impact factor: 5.923

7.  NAA-modified DNA oligonucleotides with zwitterionic backbones: stereoselective synthesis of A-T phosphoramidite building blocks.

Authors:  Boris Schmidtgall; Claudia Höbartner; Christian Ducho
Journal:  Beilstein J Org Chem       Date:  2015-01-13       Impact factor: 2.883

8.  Oligonucleotides with Cationic Backbone and Their Hybridization with DNA: Interplay of Base Pairing and Electrostatic Attraction.

Authors:  Boris Schmidtgall; Arne Kuepper; Melissa Meng; Tom N Grossmann; Christian Ducho
Journal:  Chemistry       Date:  2017-12-27       Impact factor: 5.236

9.  Enhanced Stability of DNA Oligonucleotides with Partially Zwitterionic Backbone Structures in Biological Media.

Authors:  Melissa Meng; Boris Schmidtgall; Christian Ducho
Journal:  Molecules       Date:  2018-11-10       Impact factor: 4.411

Review 10.  Oligonucleotide analogues with cationic backbone linkages.

Authors:  Melissa Meng; Christian Ducho
Journal:  Beilstein J Org Chem       Date:  2018-06-04       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.